Nowadays electricity market industry is become a major impact on power system for privatization and deregulation of power in global wise. As per the limitation of the transmission system, the complexity arises and the...
详细信息
Nowadays electricity market industry is become a major impact on power system for privatization and deregulation of power in global wise. As per the limitation of the transmission system, the complexity arises and the supply fact will be with demand at the time of balancing. The congestion of the power system is occurring based on the transmission limits of the power desire and amount for operating the system. In order to avoid transmission line congestion, enhanced sTF-LODF method is proposed. It shows the regulated line transmission flow with generating units by implementing renewable energy resources (RER) based on enhanced sTF-LODF in power systems. It avoids the congestion of transmission line frequently in the power system and manages price based on pricing and sensitivity approach, and also manages optimal location of congestion transmission and instability issues of voltage. The congestion management of Locational Marginal Pricing (LMP) is performed with minimum line loss, less cost, line flow, better sensitivity and better performances in optimal power flow and control flow. The efficiency of the proposed power system is analyzed and verified by the simulation results of tested IEEE 14 bus system.
Brainstem glioma is rare tumour in adults accounting for 1% - 2% of intracranial gliomas. In this case study, a 28-year-old female diagnosed with BG, and lesions were observed in the pons and medulla region of the bra...
详细信息
Brainstem glioma is rare tumour in adults accounting for 1% - 2% of intracranial gliomas. In this case study, a 28-year-old female diagnosed with BG, and lesions were observed in the pons and medulla region of the brain stem. she was initially treated with radiotherapy (54 Gy in 30 fractions for 6 weeks) but no change in her clinical condition and size of tumor was observed. Temozolomide (250 mg/daily for 5 days) was prescribed as first line chemotherapy. After completion of three cycles of Temozolomide, patient presented with diplopia and MRI showed increase in the size of lesions. After unsatisfactory response to radiation and chemotherapy, the patient was treated with Nimotuzumab therapy. MRI scan demonstrated the reduction of lesion size after 8 cycles of Nimotuzumab (200 mg/week). This treatment continued for another 8 cycles and the MRI scan of patients showed a significant reduction in lesion size. Nimotuzumab was found to be an effective and safe treatment option for brainstem glioma patient who was resistant to radiotherapy and chemotherapy.
暂无评论